Predictor | OR (95% Cl) | |
---|---|---|
Univariate analysis | Multivariate analysis | |
Histologic type | ||
Lobular (Ref) | 1 | 1 |
Ductal | 4.43 (0.99–19.89) | 2.16 (0.18–26.15) |
Mixed ductal/lobular | —* | —* |
Receptor subtype | ||
ER+/PR+/HER2− (Ref) | 1 | 1 |
ER+/PR−/HER2− | 3.42 (1.42–8.22) | 2.16 (0.60–7.70) |
HER2+ | 5.04 (2.72–9.33) | 2.41 (0.90–6.48) |
Triple-negative | 3.82 (1.89–7.70) | 2.39 (0.88–6.54) |
Tumour grade | ||
Low (1–2) (Ref) | 1 | 1 |
High (3) | 2.11 (1.27–3.51) | 1.78 (0.80–3.94) |
Nodal density | ||
Multiple (Ref) | 1 | — |
Single | 1.11 (0.61–2.03) | — |
Residual tumour | ||
Yes (Ref) | 1 | 1 |
No | 7.28 (4.31–12.29) | 6.74 (2.89–15.67) |
Tumour size | 0.93 (0.81–1.06) | 0.91 (0.76–1.08) |
CI = confidence interval; ER = estrogen receptor; HER2 = human epidermal growth factor receptor 2; OR = odds ratio; PR = progesterone receptor; Ref = reference.
↵* Could not be determined.